Bristol-Myers Squibb Company

Pharmaceuticals and BiotechnologyFounded 1989

Market Data Current As Of: September 12, 2026

Related Competitor Intelligence

Compare market positioning with top industry peers

Competitor

Explore Bristol-Myers Squibb

Core profile pages, annual revenue records, and related research hubs for this company.

Bristol-Myers Squibb Company

Pharmaceuticals and BiotechnologyFounded 1989

Reviewed by Swet Parvadiya

Last reviewed: September 12, 2026

Market Data Current As Of: September 12, 2026

Financial Performance

Bristol-Myers Squibb Revenue & Financials

Name: Bristol-Myers Squibb Company Annual Revenue History
Creator: CorpDigest
License: https://corpdigest.com/terms

Revenue

$48.2B

Market Cap

$105.8B

Net Income

$7.1B

Employees

34,100

Financial Analysis

Bristol Myers Squibb is operating under the looming shadow of one of the largest 'patent cliffs' in pharmaceutical history. Under CEO Christopher Boerner, the company generated exactly $45.2 billion in revenue and maintains a $105.8 billion market cap with exactly 34100 employees. The financial narrative in 2026 is entirely defined by the impending loss of exclusivity for its two blockbuster drugs: the blood thinner Eliquis and the cancer immunotherapy Opdivo. To stave off a catastrophic revenue collapse BMS is deploying its cash reserves to acquire late-stage clinical biotechs (most notably the $14 billion acquisition of Karuna Therapeutics) to rapidly rebuild its immunology and neuroscience pipelines.

Revenue Trend Analysis

YoY Change

-0.2%

2-Year CAGR

+3.5%

Peak Year

2024

Trend

Mostly Growing

Bristol-Myers Squibb Company has reported revenue across 3 fiscal years, compounding at +3.5% annually over 2 years. The most recent year saw a 0.2% decline versus the prior year. Revenue peaked in 2024 at $48.3B. Out of 2 reported periods, 1 showed growth and 1 showed a decline.

Annual Revenue History

Fiscal Year	Revenue	Net Income	YoY Change
FY2025	$48.2B	$7.1B	-0.2%
FY2024	$48.3B	N/A	+7.3%
FY2023	$45.0B	$8.0B	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

Click any row to see year details.

Related Companies

Eli Lilly and Company Novartis AG Novo Nordisk A/S Bausch Health Companies Inc.

Compare Bristol-Myers Squibb Company Revenue With Competitors

Bristol-Myers Squibb Company vs Eli Lilly and Company →Bristol-Myers Squibb Company vs Novartis AG →Bristol-Myers Squibb Company vs Novo Nordisk A/S →Bristol-Myers Squibb Company vs Bausch Health Companies Inc. →

Bristol-Myers Squibb Revenue and Financial FAQ

What was Bristol-Myers Squibb Company's reported annual revenue for FY2025?

Bristol-Myers Squibb Company reported approximately $45.2B in fiscal year 2025 with a team of 34,100 employees worldwide.

How does Bristol-Myers Squibb Company allocate capital and manage operating margins?

Bristol-Myers Squibb Company strategically balances reinvestment into core R&D with operational cost discipline, focusing on workflow automation to expand operating margins in 2026.

What is the long-term financial outlook for Bristol-Myers Squibb Company in Pharmaceuticals and Biotechnology?

Financial performance in Pharmaceuticals and Biotechnology is driven by steady cash generation and pricing power, enabling Bristol-Myers Squibb Company to reinvest in high-return strategic initiatives.

Cite or embed this data

Using these figures? Please credit CorpDigest with a link.

Cite this page

CorpDigest. "Bristol-Myers Squibb Company Revenue & Financials." CorpDigest, https://corpdigest.com/company/bristol-myers-squibb/financials.

Embed this data

<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Bristol-Myers Squibb Company reported $48B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/bristol-myers-squibb/financials" target="_blank" rel="noopener">CorpDigest — Bristol-Myers Squibb Company financials</a></div>

Related Competitor Intelligence

Compare market positioning with top industry peers

Competitor

Eli Lilly and Company

View Competitor Intelligence

Competitor

Novartis AG

View Competitor Intelligence

Competitor

Novo Nordisk A/S

View Competitor Intelligence

Competitor

Bausch Health Companies Inc.

View Competitor Intelligence

Competitor

Pfizer

View Competitor Intelligence

Competitor

Merck

View Competitor Intelligence

Explore Bristol-Myers Squibb

Core profile pages, annual revenue records, and related research hubs for this company.

Financial Analysis

Fiscal Year

Revenue

Net Income

YoY Change

FY2025

$48.2B

$7.1B

-0.2%

FY2024

$48.3B

N/A

+7.3%

FY2023

$45.0B

$8.0B

—

Bristol-Myers Squibb Revenue and Financial FAQ

What was Bristol-Myers Squibb Company's reported annual revenue for FY2025?

Bristol-Myers Squibb Company reported approximately $45.2B in fiscal year 2025 with a team of 34,100 employees worldwide.

How does Bristol-Myers Squibb Company allocate capital and manage operating margins?

Bristol-Myers Squibb Company strategically balances reinvestment into core R&D with operational cost discipline, focusing on workflow automation to expand operating margins in 2026.

What is the long-term financial outlook for Bristol-Myers Squibb Company in Pharmaceuticals and Biotechnology?

Cite or embed this data

Using these figures? Please credit CorpDigest with a link.

Cite this page

CorpDigest. "Bristol-Myers Squibb Company Revenue & Financials." CorpDigest, https://corpdigest.com/company/bristol-myers-squibb/financials.

Embed this data

<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Bristol-Myers Squibb Company reported $48B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/bristol-myers-squibb/financials" target="_blank" rel="noopener">CorpDigest — Bristol-Myers Squibb Company financials</a></div>